Importance of control group selection for evaluating antimicrobial use as a risk factor for methicillin-resistant Staphylococcus aureus bacteremia

Infection Control and Hospital Epidemiology

Volumn 26, Issue 7, 2005, Pages 634-637

  Ernst, Erika J ^a   Raley, George ^a   Herwaldt, Loreen A ^a,b,c   Diekema, Daniel J ^b,c,d  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; GLYCOPEPTIDE; METICILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; ARTICLE; BACTEREMIA; CASE CONTROL STUDY; COMORBIDITY; CONTROL GROUP; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTOR;

ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CONTROL GROUPS; CROSS INFECTION; DRUG UTILIZATION; EPIDEMIOLOGIC METHODS; FEMALE; FLUOROQUINOLONES; HUMANS; IOWA; LENGTH OF STAY; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; OXACILLIN; PATIENT SELECTION; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 23044438312     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502593     Document Type: Article

References (13)

1. Muto CA, Jernigan JA, Ostrowski BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362-386.
2. Dziekan G, Hahn A, Thune K, et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study. J Hosp Infect 2000;46:263-270.
3. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002; 49:999-1005.
4. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2003;9:1415-1422.
5. Harbarth S, Harris AD, Carmeli Y, Samore MH. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis 2001;33:1462-1468.
6. Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 2001;32:1055-1061.
7. Harris AD, Samore MH, Carmeli Y. Control group selection is an important but neglected issue in studies of antibiotic resistance. Ann Intern Med 2000;133:159.
8. Harris AD, Samore MH, Lipsitch M, et al. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococcus, and Escherichia coli. Clin Infect Dis 2002;34:1558-1563.
9. Patterson DL. Looking for risk factors for the acquisition of antibiotic resistance: a 21st-century approach. Clin Infect Dis 2002;34:1564-1567.
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
11. Fridkin SK, Steward CD, Edwards JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999;29:245-252.
12. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598-1601.
13. Crowcroft NS, Ronveaux O, Monnet DL, Mertens R. Methicillin-resistant S. aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol 1999;20:31-36.